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A  recent study in this laboratory of recurrent attacks of experi- 
mental pneumococcus lobar pneumonia in dogs (1) revealed the fact 
that while one attack results in an increased antipneumococcal im- 
munity, it is not of suflficient degree to protect the animal against 
subsequent infection with the same or even smaller infecting doses 
of pneumococci.  Evidences of increased resistance of the recovered 
dogs were (a)  regular survival from doses of culture which usually 
produced death in the dog infected for the first time,  (b)  the mild 
and brief course of the  recurrent attack,  (c)  the limitation of the 
lesion in most instances to one lobe,  (d)  the low incidence of bac- 
teremla.  Investigation into the nature of the dog's greater ability 
to withstand recurrent infections indicated that it could not be re- 
lated to the development of acquired circulating immune bodies alone 
since these substances were not found to  be  constantly present in 
the blood.  Dogs without demonstrable humoral immunity appeared 
to be just as resistant to infection as those possessing it.  However, 
a comparative study of the pathogenesis of the secondary and primary 
lesions brought out certain striking differences between the two.  The 
secondary lesions  tended  to  evolve  much  more  rapidly  and  were 
characterized by the early appearance of a  generalized macrophage 
reaction which was associated with marked diminution in the number 
of pneumococci in the tissues or their complete absence.  This char- 
acteristic  cellular transformation  of  the  inflammatory exudate  ac- 
companied  by  the  disappearance  of  the  invading  microorganisms 
has been found regularly at the time of recovery from the primary 
infection  (2).  Hence these findings in the reinfected dogs suggest 
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that  their  heightened  resistance  depends  to  a  considerable  extent 
on  an  accelerated  reactivity  of  the  pulmonary  tissue  ceils.  But 
whether the effective antipneumococcal reaction of the macrophages 
requires  the  cooperation  of  acquired  humoral  immune  substances, 
which may be present locally or in the blood in concentration below 
our methods of detection, we do not know. 
Our  reported  observations  on  recurrent  attacks  of  experimental 
pneumonia  would  indicate  that  the  degree  of  the  dog's  increased 
immunity was  not  affected greatly by the  number  of infections to 
which  it  had  been  subjected.  An  animal  having  passed  through 
eight or ten attacks appeared to be no more resistant to subsequent 
infection  than  following  the  first  one. 1  Nor  could  we  detect  any 
significant differences in  the local cellular response or the  degree of 
humoral immunity that could be related to the number of infections. 
The question then arose as to whether or not the dog's antipneumococ- 
cal resistance could be increased to the point of complete protection 
against  experimental  infection.  With  the  purpose  of  investigating 
this possibility the following experiments were undertaken. 
Materials  and  Methods 
Normal dogs,  weighing  8  to  16  kilos,  were  used.  The pneumococcus  em- 
ployed for producing infection was  the same  we have used in previous studies. 
It was of relatively high virulence for dogs, even when injected intraperitoneally 
or intrapleurally.  1 to  2  cc. regularly produced death.  Intrabronchially the 
lethal dose was  much smaller.  The technique of infection has been described 
in an earlier publication  (3).  For the sake of uniformity, the infecting dose, 
0.25  cc. of an actively growing  culture, was  always introduced into the right 
lower lobe.  This dose produced in normal dogs a severe and extensive pneumonia 
terminating fatally in approximately 65 per cent of the animals infected.  X-ray 
of the dog's chest was taken at the end of 24 hours after infection except when  the 
animal was sacrificed at this time.  The concentrated antibody solution (Felton) 
employed was  kindly given to us  by Lederle and  Company.  The dogs  were 
killed by means of rapid intravenous infection of 500 to 600 rag.  of nembutal 
which  produced  instantaneous  death.  The  tissues  were  fixed  in  5 per cent 
acetic Zenker's solution and stained  with  Wallace's  modification  of the  Gram- 
Weigert stain (4). 
1 Observations  extended since this work was completed have shown that dogs 
recovered from a number of pulmonary infections do have a greater antipneumo- 
coccal  immunity than that  acquired from a  single  attack of the experimental 
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Effects of Passive Immunization 
Although the sera of  dogs having  recovered  from  one  or  more 
attacks of the experimental disease frequently possess the property 
of passively immunizing mice against pneumococcus infection, the 
degree of such protective action is by no means as great as that which 
can be induced in the dog's blood by the injection of a large quantity 
of therapeutic immune serum.  Therefore, it was felt that our failure 
to detect any constant relationship between the presence of humoral 
immunity  and  the  recovered  dog's resistance  to  the  inception of 
experimental pneumonia did not exclude the possibility of producing 
effective protection by means of a  high concentration of circulating 
immune substances.  Accordingly, dogs were injected 15 to 20 minutes 
prior to infection with concentrated as well as raw Type I  antipneu- 
mococcus serum, in  quantities equivalent to  those customarily ad- 
ministered to pneumonia patients in the first 24 hours of the disease. 
The serum of dogs thus treated usually protected mice against 0.01 cc. 
of pneumococcus  culture, whereas the serum of recovered dogs showing 
mouse protective properties was effective against 0.0001  cc.  of cul- 
ture at most. 
The three animals thus prepared, Nos.  liB,  12B  and 48G (Table 
I), all developed a  lobar consolidation accompanied by fever.  The 
disease ran a brief course 36 to 42 hours and the lesion was confined 
to a  single lobe.  One dog, 48G,  sacrificed at the end of 42  hours, 
showed sterile cultures of the consolidated lung.  Resolution of the 
lesions in the other two  animals as determined by x-ray was very 
rapid.  Several other dogs similarly treated (not listed in the table) 
confirmed the result of this experiment, namely, that  even a  high 
concentration of  circulating antipneumococcal immune substances, 
when produced in this manner, does not protect the dog against the 
inception of the experimental disease. 
Effects  of Passive Immunization Combined with Leucocytosis 
In an earlier study of the pathogenesis of experimental canine lobar 
pneumonia (5) it was observed that the spreading margin of the lesion 
was characterized by a  peripheral zone of edema-filled air sacs con- 
taining large  numbers  of  pneumococci.  This  was  followed  by  a 
progressive  accumulation  of  polymorphonuclear leucocytes  in  the I,,,4 
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~lveoli with attendant phagocytosis of the microorganisms.  In the 
more central, i. e., older areas of the lesion, the alveoli were packed 
with  leucocytes  and  the  pneumococci had  diminished greatly  in 
numbers.  It was apparent that a certain time interval elapsed before 
the arrival of the leucocytes in numbers sufficient to check the growth 
of the invading microorganisms.  Meanwhile, the rapidly multiply- 
ing  pneumococci  brought  about  a  progressive  diminution  in the 
concentration of opsonins present.  This interval presumably allowed 
further spread of the infected edema fluid.  Were  this the correct 
account of the process, it would seem that  given a  sufficiently in- 
creased rate of mobilization of the phagocyting cells and the presence 
of an adequate concentration of opsonizing fluid, rapid termination 
of the infectious process would ensue. 
An attempt was made to produce such optimum conditions by the 
induction of a  preliminary leucocytosis.  For this purpose typhoid 
vaccine was  employed.  1  cc., of the  commercial preparation  con- 
taining 1 billion bacilli, was injected subcutaneously the day preceding 
infection.  At the height of the rise in circulating white blood cells, 
predominantly polymorphonuclear leucocytes, 20,000  units of anti- 
body solution in one instance and 30 cc. of raw immune serum in the 
other,  were  injected intravenously, followed in  15  minutes by  the 
infecting dose.  Just as in the case of the dogs with passive immuni- 
zation alone, these two  animals  (dogs 43G  and 26G,  Table  I)  de- 
veloped lobar consolidation.  One of them, 26G,  showed no rise in 
temperature but at  postmortem two-thirds of the right lower lobe 
was found to be consolidated and small areas of involvement were 
present in the right middle and upper lobes.  Cultures of the lungs 
and heart's blood were sterile in both animals, indicating that  the 
active phase of the disease had terminated within 24 hours. 
Effects of Injection  of Polymorphonuclear Leucocytes Locally 
It would appear that the induction of an antecedent leucocytosis 
added nothing detectable to the passively immunized dog's resistance. 
Was this due to the fact that the mobilization of leucocytes at the 
site of infection was not sufficiently accelerated?  With the purpose 
of determining the effect of an initial high concentration of phag- 
ocyting cells  at  the  locus of implantation, young active polymor- 712  ANTIPNEUMOCOCCAL  IMMUNITY  AND  PNEUMONIA 
phonuclear  leucocytes  in  the  calculated  proportion  of  twenty-five 
cells  to  one  pneumococcus were  mixed  with  the  starch  suspension 
containing the infecting dose of pneumococci.  2 
This procedure apparently conferred no increased protection against 
infection as shown by the finding in dog 30L of extensive consolidation 
in the lungs at the end of 24 hours, a picture similar to that produced 
by analogous doses of culture in normal animals. 
Effects of Injection  of Polymorphonuclear Leucocytes Locally 
and Antibody Solution  Intravenously 
The  next  step  was  to  produce  a  high  concentration  of  immune 
substances in the blood and an effective mobilization of the leucocytes 
locally.  The  experiment on dog 29L was designed to produce such 
conditions, but either they were not adequately induced or there were 
other unknown necessary factors lacking, for autopsy of this animal 
at 24 hours  revealed consolidation not only of the initially  infected 
lobe but also metastatic lesions to the opposite side.  Furthermore, 
pneumococci were  recovered  in  culture  from  all  the  lesions.  This 
extensive  infection  occurred  despite  a  high  degree  of  humoral  im- 
munity as shown by the fact that the dog's serum, taken immediately 
before inoculation,  protected mice against  0.01  cc.  of pneumococcus 
culture,  1 million or more lethal mouse doses. 
Effects  of Injection  of Polymorpkonuclear Leucocytes and  Antibody 
Solution  Locally 
In  order  to  produce  the  most  unfavorable  environment  for  the 
freshly implanted pneumococci that we could devise, antibody solu- 
tion  and leucocytes were mixed directly with  the  starch  containing 
the  infecting dose of culture.  The  concentration  of leucocytes was 
These leucocytes were obtained from an aleuronat pleural exudate produced 
in another  normal dog and prepared  as described in an early publication.  In 
carrying out pnenmococcidal tests with normal dog serum and leucocytes it was 
found that a ratio of 50 polymorphonuclear leucocytes to 1 pneumococcus was 
the optimum for the complete destruction of all the pneumococci present.  When 
immune serum was added to such mixtures, a ratio of 5 leucocytes to 1 pneumo- 
coccus was adequate (6, 7).  In the present work a mixture containing more than 
25 leucocytes to 1 microorganism was found to be too viscid for intrabronchial 
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the  same  as  that  in  the  preceding experiments.  The  amount of 
antibody solution used, 500 units, was calculated from our in vitro 
experiments as being in excess of that  capable of causing, in  con- 
junction with the leucocytes, the destruction of all the pneumococci 
injected (7).  Dogs 77L and  17M  (Table I)  represent experiments 
of this  type.  It  is  possible that  dog  77L was  almost  completely 
protected since there was no febrile reaction, its white count before 
death was only slightly elevated and the size of the lesion, 3 cm. in 
diameter, was not much larger than that produced by starch alone. 
Microscopically, however, the appearance of the lesion was more that 
of a  pneumococcus infection than a  starch inflammation.  Cultures 
were  sterile.  Dog  17M,  on  the  other  hand,  had  a  consolidation 
of half the lobe. 
A third dog, 75L, was given immune serum locally but no leucocytes. 
There was  a  resulting rise  in  temperature in  contrast  to  the  two 
animals receiving immune serum and leucocytes, and consolidation 
of about the same extent and character as shown by dog 17M.  How 
much importance should be  attached to fever under these circum- 
stances is not clear since certain animals (26G and 6L), developing 
more extensive lesions than shown by any of these three, exhibited 
no febrile  reaction.  The lesions in  all  three  animals were  sterile, 
indicating that recovery had occurred within 24 hours. 
The above experiments leave one in doubt as to whether the injected 
leucocytes added anything to the dog's protective mechanism.  The 
possibility that the phagocytic activity of the leucocytes might be 
impeded by the viscosity of the starch suspension was studied in vitro. 
And it was found that leucocytes mixed with starch were definitely 
less  phagocytic than  when  suspended in  serum alone.  While  the 
conditions in the capillary pipette and the lung differ in that there 
is constant movement in the latter  and a  gradual autolysis of the 
starch, it seemed not improbable that the artificially induced mobili- 
zation of the leucocytes might not be as effective at least during the 
first few hours of the disease, as that occurring naturally.  Experi- 
ments  were  therefore  devised  to  eliminate  the  interfering  action 
of the starch. 
It was first necessary to produce  fatal experimental pneumonia without the 
use of starch.  This was accomplished  by injecting 0.25 cc. of culture suspended 714  ANTIPNEUMOCOCCAL  IMMUNITY  AND  PNEUMONIA 
in 1 cc. of broth followed  by 2 to 3 cc. of a very viscid mucin,  s  Of six dogs thus 
injected all developed severe pneumonia and five died. 
Two dogs, Nos. 72Q and 73Q (Table I), were injected with mixtures of leuco- 
cytes suspended in gelatin-Locke's solution, antibody solution and pneumococci 
without starch and followed  by 2 to 3 cc. of mucin.  72Q was completely pro- 
tected.  On the other hand, a definite, though small pneumonic lesion involving 
one-fourth of the lobe developed in 73Q. 
In order to compare the effectiveness of a  small quantity of anti- 
body solution (500 units) injected locally with a large quantity given 
intravenously, dog 43Q  (Table I)  was infected in the same way as 
72Q  and  73Q  except  that  20,000  units  of  antibody  solution  were 
injected into the blood stream  1 hour and  15  minutes before giving 
the  infecting dose  of  pneumococci  mixed  with  leucocytes.  From 
the fact that all three lobes of the right lung of dog 42Q were found 
to be  consolidated at 24  hours,  it would  seem that  the leucocytes 
might have  been more of a  hindrance than a  help in the control of 
the  infection.  At  any rate,  a  high  concentration of  antibodies in 
the blood of this dog was much less effective than small amounts 
of antibody solution deposited in the site of infection as shown by the 
small lesions in the seven dogs treated in this manner. 
With the possibility that the lack of complete protection in dog 
73Q  injected with  antibody solution  and  leucocytes locally might 
have been  due to  the absence of sufficient fresh serum to  activate 
the immune bodies in the mixtures,  4 two more dogs, 61Q and 3R, were 
injected similarly, but with the difference that the leucocytes were 
suspended in fresh dog serum 0.5  to 0.75  cc.  In neither dog were 
the lesions as small as in 72Q.  Dog 3R showed consolidation of half 
the lobe.  So it seems evident that the lack of added fresh serum was 
not responsible for the failure to secure complete protection in the 
earlier experiments. 
To determine whether the limited lesions in the above experiments 
8  The use of mucin in the production of experimental pneumonia was first 
introduced successfully  by Nungester (8).  His method for the sterilization of 
mucin was employed  in this work.  The dog's chest was elevated during the pro- 
cedure to prevent possible escape of the fluid. 
4  In a previous study of the pneumococcidal  action of mixtures of rabbit serum 
and leucocytes  containing specific  antipneumococcus  serum it was found that the 
presence of a small amount of fresh normal serum was essential to the reaction (9). o.  ~.  ROBERTSON  715 
were due to actual infection, a dog, 2R, was injected with leucocytes, 
antibody solution and killed pnenmococci.  This animal, in contrast 
to the others similarly injected with live microorganisms, showed a 
rise  in  temperature  although no  increase  in  the  number of white 
blood cells, and at autopsy had a lesion a little larger than that which 
would have been produced by the inoculum alone.  In all the dogs 
injected with leucocytes locally the inoculum was 2 to 2.5 cc. so that 
an initial area  of infiltration twice that of the  1 cc.  of starch was 
produced.  The nodule found in  dog 72Q  represents such an area. 
The  results  of  these  experiments in  which  immune  serum  and 
leucocytes were artificially mobilized at the site of infection, show that 
while  complete protection was  uncommonly obtained,  a  febrile  re- 
action was unusual,  the lesions were  small and  all were  sterile by 
24 hours. 
Effects of Passive Immunization Induced 24 Hours before Infection 
Although none of the procedures employed in the preceding experi- 
ments were found to be regularly effective in preventing completely 
the inception of the experimental disease, there remained the pos- 
sibility that the administration of immune serum some time before 
infection might produce a greater degree of protection.  Accordingly, 
two dogs, Nos.  21V[ and  13iVf, were given 20,000 units of antibody 
solution 24 hours before the infecting dose of pneumococci.  Dog 23¢f 
appeared to be completely protected (Table  I).  Dog 13M,  on the 
contrary, developed an infection characterized by the consolidation 
of a whole lobe, despite the fact that its blood serum, at the end of 
24 hours, showed a high titer of mouse protective action.  The lesion 
was found to be sterile. 
Effects  of Active  Immunization  with  Vaccines  and  Live  Cultures 
Injected  Subcutaneously 
The inquiry then proceeded to ascertain whether or not the produc- 
tion of active immunity, by means of killed and living pneumococcl, 
would protect more successfully against the induction of the experi- 
mental  disease  than  did  passive  immunization.  For  this  purpose 
dogs were immunized in  various ways.  Three animals,  dogs 23H, 
38H and 6M, were injected subcutaneously with killed cultures over ~.  ~.'~ 
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a period of 2½ weeks, each animal receiving a total of 27 cc. of culture. 
5 days after the last injection the dogs were given an infecting dose 
of  culture  intrabronchially.  As  will  be  noted  in  Table  II,  lobar 
consolidation occurred in  all  three instances and  spreads to  other 
lobes were found in the lungs of the two dogs sacrificed at 24 hours. 
The disease process, however, was short lived as shown by negative 
cultures from the initially consolidated lobes and the prompt recovery 
of dog 6•  (not sacrificed).  Before infection the sera of these dogs 
showed a  considerable degree of humoral immunity,  protecting mice 
against 0.001 to 0.0001  cc. of culture. 
In an attempt to induce a  higher degree of immunity, two other 
dogs, 6L and 15L, were given a much larger amount of vaccine as well 
as  living  pneumococci.  The  results  were  not  essentially different 
from those in the dogs vaccinated less intensively.  In fact there was 
some evidence that these animals, 6L and 15L, were not as resistant, 
in that the initially infected lobes still yielded positive cultures at 
the end of 24 hours while those of the dogs receiving the smaller 
vaccine  doses  were  sterile  at  this  time.  Furthermore,  while  the 
initial titer  of mouse protective substances in  dogs 23H  and  38H 
persisted until the time of death, the serum of dog 6L showed a marked 
diminution of this property during the 24 hours of the disease. 
Effects of Intrabronchial Vaccination 
A  number of dogs were vaccinated intrabronchially by means of 
spraying suspensions of killed pneumococci directly into the lower 
bronchial tree through a  long atomizer specially devised by Tuttle 
and Cannon (10).  Since this series of experiments is not yet complete 
and will constitute the subject of a separate report, only a brief men- 
tion of the results will be made at this time.  It was found that vac- 
cination by way of the bronchi resulted in an enhancement of  the 
animal's resistance to pneumococcus infection, but not to the degree 
of preventing the inception of the experimental disease.  The results 
were in general the same as those recorded in the case of dog 56L 
(Table II).  In every instance either a considerable part or a whole 
lobe became involved, but the disease was brief and invariably re- 
sulted in  recovery.  That  the  vaccine was absorbed from the lung 
surface was indicated by development of acquired immune substances 
in the blood sera of the vaccinated dogs. t~ 
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Effects  of Combined Active and Passive  Immunization 
The question then arose as to whether the failure of either active 
or passive  immunization alone  to  completely protect dogs against 
the experimental infection might not be due to the lack of some factor 
or factors which would be supplied by the combined action of both 
processes.  This  possibility  was  tested  by  means of passively  im- 
munizing dogs which had been vaccinated subcutaneously with killed 
pneumococci  or had recently recovered from an attack of experimental 
pneumonia.  As  shown in  Table  III,  one  dog,  No.  78L,  recently 
recovered from  experimental pneumonia and  injected with  20,000 
units of antibody solution 24 hours preceding infection, developed a 
lesion involving two-fifths of the lobe but without fever.  The vac- 
cinated dog, No.  30N,  similarly treated,  showed only a  small area 
of consolidation which was, however, two to three times as large as 
that  which would be produced by the  starch alone.  Both lesions 
were sterile at  postmortem.  Just where to place the line between 
complete and  incomplete inhibition of infection, we  do not know. 
In view of the fact that a  sterile inoculum consisting of leucocytes 
and killed pneumococci (dog 2R, Table I) caused an area of consolida- 
tion as large as that found in 30N, it may be that the latter animal 
should be considered to have been completely protected. 
Comparison  of the Protective Effect  of Active 
versus Passive Immunization 
A  general  comparison of  the  characteristics  of the  experimental 
infections produced in  dogs  actively immunized by  recovery from 
an attack of the disease or vaccinated in the various ways described 
above, with those observed in animals passively immunized by intra- 
venous injection of large quantities of highly potent immune serum, 
suggested  that  the  latter  procedure  induced  a  somewhat  greater 
degree of protection than did the former.  It seemed worth while to 
pursue this subject further by means of testing the efficacy of the 
two types of immunity with highly lethal doses of pneumococci.  In 
a  recent series of experiments on the relationship of dosage to  the 
outcome of experimental pneumonia it was found that implantation 
of the infecting dose, contained in 4  to 6  cc. of starch, into several 
different areas in the lung produced a much higher mortality than did 720  ANTIPNEUMOCOCCAL  IMMUNITY  AND  PNEUMONIA 
similar amounts of culture contained in  1 cc.  of starch)  The dose 
chosen for the present test was 0.6 cc. culture, an amount which killed 
normal dogs within 24 to 48 hours. 
Two  animals were  compared as follows: Dog 6M  had had  three 
previous attacks of lobar pneumonia, all in the right lower lobe, the 
last  one  2  weeks  before  infection with  the  lethal  dose  which was 
initiated also in the right lower lobe.  The normal dog, 26M, received 
20,000  units of antibody solution 24  hours before infection.  Tests 
on the blood serum taken just before the infecting dose showed that 
the  serum  of  6M  protected  against  10  -4  dilution of  culture  while 
that  of  26M  protected  against  10  -3.  Both  dogs  survived.  The 
brief course of the disease--2 to 3 days--, the extent of consolidation 
(lower  and middle lobes)  and  the  absence  of bacteremia were  the 
same in the two animals.  The only difference between them was the 
occurrence of a  marked leucopenia in the recovered dog at the end 
of 24 hours while in the passively protected animal the white blood 
cells fell only to a low normal count.  With this exception the actively 
immunized dog appeared to be as resistant to the experimental infec- 
tion as was the passively immunized one. 
Since the above experiments were carried out several other dogs, 
having recovered  from one  or  more  attacks  of experimental lobar 
pneumonia, were reinfected after 10 days to 2 weeks with the same 
lethal dose of pneumococci as was given to dogs 6M and 265I.  These 
animals passed through a brief infection without showing an accom- 
panying leucopenia. 
Pathology 
Most striking feature of histological  pathology of these lesions was the pres- 
ence of a macrophage reaction  6 24 hours after the inception of the disease.  In 
normal animals the same degree and extent of this cellular change was not ob- 
5  Unpublished work. 
6  The  cellular transformation of  the  lung  parenchyma  and  intra-alveolar 
exudate designated under the term "macrophage reaction" has been described by 
Robertson and coworkers in detail in former publications (1, 2).  Briefly  it con- 
sists of an increase in the number and size of large mononudear cells in the al- 
veolar walls, which become detached from the septa and enter the air spaces 
where they assume the appearance and functions of the free histiocyte or macro- 
phage. o.  H.  gOBERTSON  721 
served to occur before 40 to 48 hours.  The majority of the twenty-two animals 
studied  showed  a  macrophage reaction in its  beginning  stages,  i.e.,  thickened 
septa  containing numerous large  mononudear cells, many of which  protruded 
into the alveolar spaces but relatively few free.  In most instances  the reaction 
was generalized, in a few focal in distribution.  Three of the dogs exhibited the 
cellular  change  in a  moderately advanced form.  In three others it was  very 
slight  and focal in distribution, no more than is sometimes  seen in primary in- 
fections at 24 hours.  In all but one of the dogs (430.) showing metastatic lesions, 
the macrophage reaction was more marked in the newer process than it was in 
the original one.  Likewise, with a single exception (dog 29L), the reaction was 
greater at the spreading  margin of the lesion than at its center.  This was, of 
course, not true of the three animals in which there was a well marked response 
of the macrophages  throughout the inflavamatory  area.  The predominant cell 
type even in these three dogs was the polymorphonudear leucocyte. 
Just as found in former studies (1, 2) pneumococci were few or absent in areas 
of macrophage accumulation.  In only four of the dogs were pneumococci  cul- 
tured from the lungs 24 hours after the inception of the infection.  One of these, 
30L, received only leucocytes with the infecting dose.  Two, dogs 6L and 15L, 
were vaccinated with large quantities of killed and live cultures subcutaneously. 
The  fourth  animal,  No.  29L,  injected  with  antibody solution  intravenously, 
developed only a small area of consolidation  and was the single one of the four 
in which the lesions showed a macrophage reaction.  This reaction in the initial 
lesion was slight  in degree, focal in character and not present at the periphery 
where  pneumococci  were  observed both  free and  intracellular.  In  the  more 
central portion of the process only a few intraceUular microorganisms  were seen. 
The metastatic lesions in dog 29L were characterized by a more pronounced and 
generalized  macrophage response  and,  with  the exception of a  very occasional 
intracellular form, the absence of pneumococci.  In most of the sterile lung lesions 
pneumococci could not be detected.  In some, microorganisms  were observed to 
be undergoing digestion,  principally within the macrophages. 
DISCUSSION 
Previous studies on the prevention of experimental pneumococcus 
pneumonia  have  dealt  almost  entirely  with  the  protective  effects 
of vaccination by various routes.  Cecil  and  Blake  (11)  found that 
saline  and  lipoid  Type  I  pneumococcus  vaccines  injected  subcu- 
taneously failed  to  protect  monkeys against  intratracheal  infection 
with  virulent  microorganisms  of  the  same  type,  but  the  ensuing 
pneumonia  was  milder  than  in  the  non-vaccinated  controls  and 
bacteremia  usually  slight.  Employing  living cultures  in  the  same 
manner they were able to induce a greater degree of protection which 
in  two instances  was  apparently  complete  (12).  However, some of 722  ANTIPNEU~0COCCAL  IMMUNITY  AND  PNEUMONIA 
the monkeys showed marked reaction to  the vaccination and even 
gave  evidence of  actual infection.  Cecil and  Steffen  (13)  pursued 
the investigation further, using very much larger doses of heat-killed 
pneumococci subcutaneously, a  total of  120 billion microorganisms 
in three doses.  They were able by this means to secure complete 
protection against  the  inception of  experimental lobar  pneumonia 
with Types I, II and group IV.  Equally good results in the case of 
pneumococcus Type I  were obtained by injecting the vaccine intra- 
tracheally.  However, the same amount of vaccine sprayed into the 
trachea failed to protect.  Cecil and Blake (14) reinfected two mon- 
keys which had recovered from Type I  lobar pneumonia and found 
them to  be  immune to  infection with the  homologous type pneu- 
mococcus.  Whether  the  difference  between  the  results  of  these 
workers and our own lies in the animal species employed or in the 
method of inducing the experimental disease, we do not know.  Find- 
ings much more nearly comparable to ours in dogs were obtained by 
Stuppy,  Cannon  and Falk  (15),  in  rabbits  protected by means of 
killed  cultures of  Type I  pneumococci sprayed into  the  nose  and 
throat and also injected into the buccal mucosa.  Animals immunized 
by either route survived lethal doses of virulent pneumococci  intro- 
duced by intrabronchial insuffiation.  They showed pulmonary lesions 
which were, however, of limited extent and in the three rabbits killed 
at 24 or 48 hours after infection were found to be  sterile.  Micro- 
scopical examination of these lesions revealed a  marked reaction of 
the pulmonary macrophages. 
A comparison of the effects produced in the dog by the injection 
of pneumococci in various sites indicates that  the implantation of 
starch-suspended microorganisms into the terminal air spaces of the 
lung provides a  peculiarly favorable environment for their growth. 
Doses of broth culture, many times the amount required to produce 
pneumonia, when injected into the blood stream or under the skin 
of normal dogs were found to excite little or no reaction.  Our suc- 
cessful production of pneumonia by  the  injection of  pneumococci 
suspended in  1 co. of broth followed by 2  to 3  cc. of mucin which 
occludes the terminal bronchus completely, suggests that the most 
important  function of  the  starch  may  be  that  of  preventing the 
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Nungester and Jourdonais (8)  found that the invasiveness of pneu- 
mococci for  rats was  enhanced by suspension in  mucin.  While in 
the present work the mucin was injected after the infecting dose of 
pneumococci,  a  certain  admixture  of  microorganisms  and  mucin 
probably occurred, especially since mucin so injected has been found 
not only at the site of insertion but also in neighboring bronchi 6 to 9 
hours  afterwards.  Starch  also  protects the  pneumococci from the 
phagocyting cells as we found in our opsonin tests i~ vitro.  However, 
this latter effect is evidently o~ limited duration, since within an hour 
after the initiation of the primary lesion pneumococci were observed 
in alveolar spaces and to some extent in the alveolar walls at a  con- 
siderable distance from the locus of implantation (5).  By the end 
of 4 to 6 hours all traces of the starch had disappeared.  Therefore 
it would seem that once the disease has been initiated, the action 
of the starch, whatever it may be, ceases to operate.  Certainly it 
can  have nothing to  do  with the inception of the later metastatic 
lesions.  The  occasional  occurrence  of  such  lesions  in  highly  im- 
munized dogs is another evidence of the disadvantage at which the 
body is placed when pneumococci gain entrance to the alveolar units. 
For this reason it would seem to us that the method we have employed 
for testing the animals' power to resist the inception of lobar pneu- 
monia is more exacting than those previously used, since in the lat- 
ter many of the injected pneumococci probably never reached the 
alveolar spaces. 
The results of the experiments described in this study provide some 
further insight into the mechanism by which the body brings about 
the  termination of growth and  the destruction of pneumococci in 
the lungs but leave much of the problem unsolved.  The supposition 
(advanced earlier)  (5) that a high concentration of antipneumococcal 
immune substances and phagocyfing cells at the site of infection would 
quickly bring about a termination of the process is borne out in the 
main  by  the  present  observations.  However,  the  optimum con- 
ditions for securing such mobilization of the body's defenses remain 
obscure.  The occurrence of lobar or multilobar consolidation in a 
number of the passively as well as in the actively immunized animals 
leaves no doubt that even a very high concentration of specific immune 
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extensive lesion.  A  preliminary artificial mobilization of polymor- 
phonuclear leucocytes at the site of infection appeared to contribute 
no added protection.  It was only when immune bodies and leucocytes 
were implanted with the infecting dose of pneumococci  that a constant 
early inhibition of the infection occurred.  7 
The fact that several of the passively immunized dogs were found 
to be  completely or  almost completely protected suggests that  in- 
dividual animals vary greatly in  the  rate  at  which the  defensive 
dements of the blood can be mobilized at the site of infection.  Even 
in those animals developing fairly extensive consolidation the rate 
of destruction of pneumococci was much greater than in the normal 
dog as shown by the sterile cultures of the lesions at 24 hours. 
We have no direct evidence in this study that the immune serum 
has any action other than that of promoting phagocytosis and in- 
tracellular digestion.  However, the markedly circumscribed nature 
of some of the initial loci of consolidation suggests that it may exert 
additional localizing effects described by Rich (19) and Catron (20), 
namely agglutination and adhesion of the pneumococci to  the  tis- 
sue ceils, s 
The early appearance of a  macrophage reaction observed in the 
lesions brings up the question of the possible  rSle played by these 
cells in termination of the infectious process.  While it seems probable 
that the polymorphonuclear leucocytes were chiefly responsible for 
the  destruction of pneumococci since  they were  the  predominant 
cell of the inflammatory exudate, the finding that the macrophage 
response was most pronounced in the young metastatic lesions  and 
at the margin of the initial loci of consolidation suggests a condition 
analogous to that which we have found to occur early in the lesions 
of recurrent infections produced at the site of a previous pneumonic 
7 The recent studies of Goodner and HorsfaU and Bauer (16,  17)  and Heidel- 
berger and Pedersen (18) on the relative sizes of the horse and rabbit globulin 
molecules suggest the possibility that the smaller molecular  size of the rabbit 
antipneumococcus  immune  bodies might permit their exudation into the inflam- 
matory area in greater concentration  than is possible with immune  substances of 
horse serum. 
s Cannon and Pacheco had previously described this effect in staphylococcus 
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process.  Such  infections,  usually  brief  and  relatively  mild,  were 
characterized  by  pulmonary lesions exhibiting a  much accelerated 
macrophage reaction.  This was seen sometimes within 6 hours after 
the infecting dose of culture and just as in the case of the metastatic 
lesions described above, wherever the reaction was marked, pneumo- 
cocci were few or absent.  It is of considerable interest to note that 
there  was  no  essential  difference in  cellular  reaction  between  the 
animals actively and passively immunized. 
The exact beating of these experiments on the immunization of 
human beings against pneumonia is  not clear  since we have little 
information concerning the  mode of origin of the  human disease. 
Nevertheless our findings do suggest the kind of result that may be 
expected from any successful specific prophylactic procedure.  It is 
beyond the scope of this communication to discuss the subject of the 
prevention of  pneumonia by  means  of  pneumococcus vaccines  or 
certain derivatives of the pneumococcus.  The success of the earlier 
work in  this field has  been  questioned.  9  More  recently,  however, 
Lister and Ordman (22) and Peall (23) have reported a marked lower- 
ing of both  morbidity and  mortality from pneumonia among the 
laborers in certain South African mines by means of mixed vaccines 
comprising various types of pneumococci and other microorganisms 
commonly producing  or  complicating  pneumonia.  The  inference 
which might be drawn from our results is that no matter how successful 
the procedure employed to increase the resistance of human beings 
to pneumococcus infection, there will be a certain percentage of such 
persons who will acquire the disease but the lesion will tend to be of 
limited extent and the infection of brief duration.  We have observed 
one case of this kind due to pneumococcus Type II which terminated 
in the 18th hour.  Serum secured shortly after onset showed a high 
concentration  of  heat  stable  Type  II  antipneumococcus immune 
substance. 
SUMM_4~Y 
In view of the finding that one or more attacks of pneumococcus 
lobar  pneumonia experimentally induced in  dogs failed  to  protect 
9 This subject has been reviewed by Felton, Sutliff and  Steele (24),  Gautier 
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the animals against subsequent infection, an attempt was made to 
determine  whether  or  not  the  dog's  antipneumococcal immunity 
could be  enhanced to  the degree of complete resistance to the ex- 
perimental disease.  To this end dogs were passively immunized by 
the intravenous injection of large quantities of both unconcentrated 
antipneumococcus horse serum and concentrated antibody solution 
and actively immunized by vaccination with killed and living cultures 
of pneumococci.  None of these procedures were found to result in 
constant protection against the pulmonary infection.  The disease, 
however,  was  of brief  duration,  the  lesions of limited extent  and 
usually sterile within 24 hours.  A combination of active and passive 
immunization produced no better results.  It was only when immune 
bodies and leucocytes were implanted with the infecting dose that 
prevention of infection was  secured with any degree of constancy. 
Even under these conditions the lesion sometimes involved a  con- 
siderable portion of a  lobe.  The factors involved in the inception 
of experimental lobar pneumonia are discussed and the bearing of 
this study on the prophylactic immunization of human beings against 
pneumococcus  pneumonia is suggested. 
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